3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I–II study (ADA-RT-1)-Reference-Cited by-同舟云学术

3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I–II study (ADA-RT-1)

Published:2011-03 Issue:3 Volume:120 Page:485-488
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Macchia Gabriella,Ferrandina Gabriella,Deodato Francesco,Bibbò Romina,Massaccesi Mariangela,Ippolito Edy,Cellini Numa,Scambia Giovanni,Valentini Vincenzo,Morganti Alessio Giuseppe

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference21 articles.

1. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study;Keys;Gynecol Oncol,2004

2. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma;Creutzberg;Lancet,2000

3. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study;Sedlis;Gynecol Oncol,1999

4. Clinical outcome of tailored adjuvant postoperative chemoradiotherapy in IB FIGO stage cervical cancer;Fabrini;Anticancer Res,2009

5. A systematic overview of radiation therapy effects in uterine cancer (corpus uteri);Einhorn;Acta Oncol,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology);La radiologia medica;2024-08-28

2. Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial;International Journal of Radiation Oncology*Biology*Physics;2016-11

3. Clinical research in a peripheral radiotherapy department: a feasibility analysis;Journal of Medicine and the Person;2015-03-06

4. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison;Acta Oncologica;2013-09-19

5. Comparisons of 5-aminolevulinic acid photodynamic therapy and after-loading radiotherapy in vivo in cervical cancer;Clinical and Translational Oncology;2012-10-02